Raphael Rifkin-Zybutz
-
adverse events, antidepressants, British Journal of Psychiatry, clinical trial, depression, difficult-to-treat depression, Editor Eimear Foley, feasibility, major depressive disorder, mdma, MDMA-assisted psychotherapy, open label study, placebo, proof-of-principle, psychedelics, psychotherapy, randomised controlled trial, remission, Safety, Suicidal Ideation, tolerability, topicalMDMA-assisted therapy for depression: a promising but early first step
MDMA was first made in 1912 as an accidental byproduct of a…
